Logo Image
News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsShortsSponsored WebcastStudent VoicesThe Weekly DoseWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
All PublicationsPharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthThe Bispecifics NetworkEducated PatientInformation for the PharmacistInteractive ToolsPartnersPulse PointSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Endometrial Cancer
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Christine Roussel, BS, PharmD, BCOP, BCSCP

Advertisement

Articles by Christine Roussel, BS, PharmD, BCOP, BCSCP

FDA, USP Advance Standardization, Regulation of Cannabis Nationally

ByChristine Roussel, BS, PharmD, BCOP, BCSCP,Megan Schwartz, BS, PharmD Candidate 2024
July 14th 2023

Quality standards and national regulation help to establish its role as medicine.

USP, FDA Propose Quality Standards for Cannabis, Highlighting its Role as Medicine

ByChristine Roussel, BS, PharmD, BCOP, BCSCP,Megan Schwartz, BS, PharmD Candidate 2024
March 3rd 2023

This action is of considerable significance as it supports the regulation of cannabis and cannabis-derived products as medicine under the Federal Food, Drug and Cosmetic Act.

Advertisement

Latest Updated Articles

  • FDA, USP Advance Standardization, Regulation of Cannabis Nationally
    FDA, USP Advance Standardization, Regulation of Cannabis Nationally

    July 14th 2023

  • USP, FDA Propose Quality Standards for Cannabis, Highlighting its Role as Medicine
    USP, FDA Propose Quality Standards for Cannabis, Highlighting its Role as Medicine

    March 3rd 2023



Advertisement
Advertisement

Trending on Pharmacy Times

1

Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging

2

Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause

3

Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL

4

New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum

5

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant Treatment of High-Risk Clear Cell RCC

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us